Indian market expected to grow 12% during 2011-15

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

New Delhi: The global business intelligence firm, ResearchandMarket has filed their latest report with their projections...Read more

US court lifts temporary injunction against Hanmi

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2013

Singapore: US Court of Appeals for the Federal Circuit (CAFC) has lifted a temporary injunction against the US launch of...Read more

Indian firms get FDA approval for 110 generic drugs

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2013

Singapore: India pharmaceutical companies have yet again emerged as the biggest overseas sources of medicines sold in th...Read more

Simcere Pharma sells Boda subsidiary for $65 mn

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2013

Singapore: Simcere Pharma has agreed to sell its 99.99 percent stake in Jilin Boda Pharma for $65 million. The company f...Read more

Actavis files ANDA for Reckitt generic with FDA

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Oct, 2013

Singapore: Actavis has filed an abbreviated new drug application (ANDA) with the US FDA seeking approval to market Bupre...Read more

Teva restructures organization model

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2014

Singapore: Global pharmaceutical company, Teva Pharmaceutical, is restructuring its management and organizational functi...Read more

Bayer appoints a new President

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2014

Singapore: Bayer pharmaceuticals announced changes in the top management, declaring Mr Dieter Weinand as the president o...Read more

Lupin begins trial runs at Nagpur's Mihan unit

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

Mumbai: Indian drug giant Lupin Pharma has begun trial run at Mihan that it expects to become fully functional in two ye...Read more

Dr. Reddy's launches generic of Singulair oral granules

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Sep, 2012

Bangalore: India-based Dr. Reddy's Laboratories has launched its montelukast sodium oral granules, a bioequivalent gene...Read more

Daiichi Sankyo generics' unit to launch 5 drugs

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 Dec, 2012

Singapore: Daiichi Sankyo's pharmaceuticals subsidiary, Daiichi Sankyo Espha is all set to launch five generic products ...Read more

Aurobindo receives FDA approval for Nevirapine

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

Bangalore: India-based Aurobindo Pharma has received final approval from the US Food & Drug Administration for Nevir...Read more

Another Indian pharma company rapped by FDA

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 22 Oct, 2013

Singapore: After reports of Indian drug majors Ranbaxy Laboratories, Aurobindo Pharma, Dr Reddy's Laboratories and Wockh...Read more

Mitsubishi Tanabe files NDA for Canagliflozin

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 May, 2013

Singapore: Mitsubishi Tanabe Pharma announced that the company has submitted an application for the manufacturing and ma...Read more

Mylan to develop, market Biocon generic insulin

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Feb, 2013

Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generi...Read more

Australia's Mayne Pharma launches Doryx in US

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

Singapore: Mayne Pharma Group has announced the launch of Doxycycline Hyclate Delayed-Release tablet in the US through t...Read more

The US coaxing India to relax patent laws: MSF

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Oct, 2014

Singapore: Medical Charity, Medecins Sans Frontieres (MSF) has condemned the US for mounting pressure on India's new gov...Read more

FDA approves Novo Nordisk haemophilia A drug

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Oct, 2013

Singapore: U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's Biologics License Application (BLA) for r...Read more

Sun Pharma settles Gleevec compound litigation

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 20 May, 2014

Singapore: Novartis Pharmaceuticals has reported to settle its litigation with US subsidiary of India based Sun Pharmace...Read more